accessiontherapeutics.com

.com crawl

First seen 2026-04-27 · Last seen 2026-05-17 · ok HTTP/1.1 200 5964 ms crawled 2026-05-04

US · 23.236.62.147 · AS396982 Google LLC

Reputation 100/100

sector health type homepage

HTML metadata

Title
Immuno-oncology | Accession Therapeutics
Description
Accession Therapeutics Limited is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity.
Language
en
Generator
Wix.com Website Builder
Canonical
https://www.accessiontherapeutics.com
Feeds

Open Graph

url
https://www.accessiontherapeutics.com
title
Immuno-oncology | Accession Therapeutics
site name
Accession
description
Accession Therapeutics Limited is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour diversity.

Technology

Server
Pepyaka
CMS
Wix

Third-party hosts loaded (4)

  • static.wixstatic.com×12
  • static.parastorage.com×10
  • siteassets.parastorage.com×4
  • browser.sentry-cdn.com×1

Social

Registration

Registrar
GoDaddy.com, LLC
Created
2020-11-10
Expires
2026-11-10 173 days left
Updated
2024-11-11
Name servers
  • ns73.domaincontrol.com
  • ns74.domaincontrol.com

DNS records live

NS
  • ns73.domaincontrol.com
  • ns74.domaincontrol.com
MX
  • 0 accessiontherapeutics-com.mail.protection.outlook.com
TXT
  • v=verifydomain MS=3128328
  • v=spf1 include:spf.protection.outlook.com include:spf.mandrillapp.com include:_spf.psm.knowbe4.com -all
  • graphpad.com:domain-verification=EVgqOKgoV0P_amarLn7r1w
Verified for
  • Apple

Certificate (current)

R12
from 2026-03-11 to 2026-06-09
Expires in 20 days

HTTP security headers

Header hygiene 60/100 Checked live page: https://www.accessiontherapeutics.com/

present
  • strict-transport-security
  • x-content-type-options
findings
  • missing Content Security Policy
  • missing frame protection
  • missing Referrer Policy
  • missing Permissions Policy
Header values
x-content-type-options
nosniff
strict-transport-security
max-age=31556952

Links to (1)

Linked from (2)